News | May 05, 2026
Eton Pharmaceuticals relaunches HEMANGEOL with new distribution model
The company says the product will now be distributed exclusively through Anovo Specialty Pharmacy
The company says the product will now be distributed exclusively through Anovo Specialty Pharmacy
Enterprise-scale adoption in 2026 will be driven by domain-specific AI, compliance automation, and strong digital foundations across quality, manufacturing and regulatory workflows
Precision medicine company advances Raman spectroscopy-based therapeutic drug monitoring platform for rapid, patient-specific dosing solutions
New policy aims to standardise screening, diagnosis and lifelong care for children with diabetes across India’s public health system
The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 3 to 6 against recommending camizestrant in combination with a CDK4/6 inhibitor
The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
Subscribe To Our Newsletter & Stay Updated
